Galectin Therapeutics CEO Joel Lewis' 2023 pay slips 1% to $964K
Galectin Therapeutics reports 2023 executive compensation
By ExecPay News
Published: December 3, 2024
Galectin Therapeutics reported fiscal year 2023 executive compensation information on December 3, 2024.
In 2023, three executives at Galectin Therapeutics received on average a compensation package of $765K, a 2% decrease compared to previous year.
Average pay of disclosed executives at Galectin Therapeutics
Joel Lewis, Chief Executive Officer, received $964K in total, which decreased by 1% compared to 2022. 60% of Lewis' compensation, or $574K, was in salary. Lewis also received $289K in bonus, $56K in option awards, as well as $45K in other compensation.
Pol F. Boudes, Chief Medical Officer, received a compensation package of $770K, which decreased by 3% compared to previous year. 69% of the compensation package, or $530K, was in salary.
Jack W. Callicutt, Chief Financial Officer, earned $561K in 2023, a 1% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on December 3, 2024.